Dr. Thomas Michael Ciesielski, MD

Dr. Ciesielski practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Ciesielski's NPI, 1932420338, was assigned on June 20, 2010. Dr. Ciesielski graduated from Emory University School of Medicine in 2010. Dr. Ciesielski holds Missouri license 2012011929.

Dr. Ciesielski's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Ciesielski also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Ciesielski's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Ciesielski to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ciesielski practices, 2 sites in all. Vendor and product names are available with a free account.

General practice is Dr. Ciesielski's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Dr. Ciesielski is licensed in Missouri.

CMS data shows 156 Medicare services from Dr. Ciesielski across 3 procedure codes in 2024, for 135 Medicare patients. Medicare paid $6,313 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 135 Medicare patients who saw Dr. Ciesielski in 2026. The largest group is under 65, with 54 patients. 75% of them have high blood pressure, and 61% have high cholesterol. 64% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ciesielski's median patient age at 64, with 56% women.

In 2026, Dr. Ciesielski wrote 171 Medicare Part D claims for 45 patients. 80% of them were for generic drugs. CMS names the drug for 49 of them, across 3 drugs with 11 or more claims each, at $383 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Ciesielski for performance year 2026, reported as part of a group. Dr. Ciesielski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Ciesielski, published from 2022 to 2024. The most frequent topics are COVID-19, Internship and Residency and Pandemics. Dr. Ciesielski's most frequent co-authors are Michael M. Awad, DO, Dominic Emmanuel Sanford, MD and Geoffrey S. Cislo, MD.

CMS Open Payments shows 1 general payment to Dr. Ciesielski from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $89.

Dr. Ciesielski graduated from Emory University School of Medicine in 2010.